Search
Filter Results
Displaying 441–450 of 960 results
-
Jan 7, 2021
REGENXBIO’s Wet AMD Gene Therapy Moving into Phase 3 Trials
In a Phase ½ clinical trial, the emerging treatment reduced the burden of regular anti-VEGF injections
-
The Foundation’s Strategic Council is a group of young professionals with an affinity to the Fighting Blindness mission and represent the next generation of Foundation leaders.
-
Dec 21, 2020
At seven years old, Hannah had never seen a lightning bug in the summer or a star in the sky. But after her treatment with LUXTURNA, Hannah can now play outside at night with her brothers and has a new bright future in store.
-
A friendly year end reminder to make sure you are aware of a popular end-of-year giving opportunity. In 2020, organizations like the Foundation Fighting Blindness have seen a huge uptick in gifts made through appreciated stock/securities. This is a great way to avoid capital gains taxes AND support a mission that’s important to you.
-
Dec 16, 2020
Round was led by Sofinnova Investments with participation from Abingworth, Lightstone Ventures and all existing investors.
Company expands board of directors and plans to build out team.
-
Dec 14, 2020
This December 17th exclusive conversation and acoustic performance by Kodi Lee of America’s Got Talent will raise awareness and funds to find treatments and cures for blinding diseases.
-
Dec 14, 2020
End Blindness 2020 Award Winners include Five Foundation-Funded Investigators
Live stream ceremony will include Art Garfunkel, Diane Schuur, and Margaret Atwood. A tribute will also be made to Justice Ruth Bader Ginsburg.
-
Dec 10, 2020
Mr. Ginsberg brings twenty-five years of rare disease corporate development, finance, strategy, and investment leadership experience.
-
Dec 7, 2020
Penn Vet’s William Beltran Elected to the National Academy of Medicine
The veterinary researcher’s canine studies are advancing promising retinal therapies toward clinical trials
-
Dec 3, 2020
Acquisition significantly expands Janssen’s eye disease portfolio and strengthens its gene therapy capabilities. Late-stage AMD affects millions of people with no effective treatments currently available .